Sphingolipids
Invitrogen™ BODIPY™ TR Ceramide complexed to BSA
Can be used in sphingolipid transport and metabolism mechanisms
Invitrogen™ BODIPY™ FL C5-Ceramide (N-(4,4-Difluoro-5,7-Dimethyl-4-Bora-3a,4a-Diaza-s-Indacene-3-Pentanoyl)Sphingosine)
Useful in cellular imaging and cell tracing and tracking
Invitrogen™ NBD C6-Ceramide Complexed to BSA
Selective stain for Golgi apparatus in live and fixed cells
Invitrogen™ BODIPY™ FL C5-Lactosylceramide complexed to BSA
The green-fluorescent BODIPY™ FL C5 lactosylceramide complexed to BSA can be used in sphingolipid transport and metabolism mechanisms.
Invitrogen™ BODIPY™ FL C5-Ceramide complexed to BSA
Can be used in sphingolipid transport and metabolism mechanisms
Invitrogen™ NBD C6-Ceramide (6-((N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)amino)hexanoyl)Sphingosine)
Selective stain for Golgi apparatus in live and fixed cells
![Medchemexpress LLC N-[(1S,2R,3E)-1-(hydroxymethyl)-2-hydroxy-3-heptadecen-1-yl]tetracosanamide | 34435-05-7 | 99.9% | 650.11 g/mol | C42H83NO3 | 5 MG](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000223383.png-250.jpg)
Medchemexpress LLC N-[(1S,2R,3E)-1-(hydroxymethyl)-2-hydroxy-3-heptadecen-1-yl]tetracosanamide | 34435-05-7 | 99.9% | 650.11 g/mol | C42H83NO3 | 5 MG
C24-ceramide is a long-chain ceramide (N-lignoceroyl-D-erythro-sphingosine) used in biochemical research to investigate sphingolipid signaling, apoptosis, and mTOR pathway modulation. Supplied as a white to off-white solid, it is intended for in vitro and cellular studies and is soluble in ethanol and THF with ultrasonic assistance.
- Purity of 99.9% for reliable experimental consistency.
- White to off-white solid form for easy handling and storage.
- Soluble in ethanol and THF with sonication for preparation of stock solutions.
- Stable when stored frozen as powder to preserve integrity.
- Suitable for studies of PIP4K2C, mTOR signaling, and sphingolipid biology.
![eMolecules AstaTech / BODIPY 576/589 / 5mg / 713369065 / E83292 / 95.000 / 150173-78-7 / [null] / 329.110 / C16H14BF2N3O2](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502510977.JPG-250.jpg)
eMolecules AstaTech / BODIPY 576/589 / 5mg / 713369065 / E83292 / 95.000 / 150173-78-7 / [null] / 329.110 / C16H14BF2N3O2
AstaTech / BODIPY 576/589 / 5mg / 713369065 / E83292 / 95.000 / 150173-78-7 / [null] / 329.110 / C16H14BF2N3O2
Cayman Chemical C16 Ceramide d18 1 16 0
A sphingolipid; levels are increased by PPMP or MAPP in isolated human neutrophils and are correlated with an increase in apoptosis; accumulates in the lungs of patients with cystic fibrosis compared with the lungs of patients with pulmonary hypertension; plasma levels are increased in patients with acute coronary syndrome, and an increased plasma ratio of C16 to C24:0 ceramide is associated with major adverse cardiac events; levels are increased in tumor tissue from patients with breast cancer and is associated with metastatic cancer